Published online Nov 27, 2026. doi: 10.4240/wjgs.124030
Revised: August 19, 2026
Accepted: October 9, 2026
Published online: November 27, 2026
Processing time: 124 Days and 18.9 Hours
Evidence regarding the risk factors for and clinical management of acute kidney injury (AKI) following liver cancer (LC) ablation remains limited.
To investigate the incidence and potential risk factors for AKI following LC ablation and explore relevant clinical preventive strategies.
This retrospective study included 168 patients with LC who underwent ablation between May 2022 and February 2026. Patients were classified into AKI (n = 25) and non-AKI (n = 143) groups according to postoperative AKI occurrence. Baseline characteristics, tumor-related characteristics (laterality, TNM stage, tumor size, tumor number, and ablation type), and laboratory parameters were compared between groups. Univariate and multivariable logistic regression analyses were performed to identify factors associated with AKI after LC ablation.
Age, diabetes, TNM stage, tumor size, hemoglobin (Hb), uric acid (UA), and serum creatinine (SCr) differed significantly between groups. Univariate analysis identified older age, diabetes, larger tumor size, higher UA, and higher SCr levels as potential risk factors, while higher Hb was associated with a lower risk of AKI. Multivariate analysis identified Hb and SCr as independent factors associated with AKI, with higher Hb associated with a lower risk [odds ratio (OR): 0.908, 95% confidence interval (CI): 0.867-0.950, P < 0.001] and higher SCr associated with an increased risk (OR: 1.040, 95%CI: 1.004-1.078, P = 0.031).
Lower preoperative Hb and higher preoperative SCr levels may increase the risk of AKI after LC ablation. Preoperative anemia management and renal function assessment may help identify high-risk patients and guide individualized perioperative renal protection strategies.
Core Tip: This retrospective study evaluated risk factors for acute kidney injury (AKI) after liver cancer (LC) ablation in 168 patients (AKI group, n = 25; non-AKI group, n = 143). Low preoperative hemoglobin and high creatinine levels were independently associated with increased AKI risk after LC ablation. Preoperative anemia management and careful renal function monitoring may help identify high-risk patients and guide perioperative renal protection.